Skip to main content
Caplight Logo









Sundance Biosciences

Sundance Biosciences

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://sundancebio.com

Company Overview

Sundance Biosciences operates in Healthcare & Life Sciences and is based in South San Francisco, California. It was founded in 2025.

Sundance Biosciences is a biotechnology company that develops oral therapies targeting TYK2 for the treatment of multiple sclerosis and other immune-mediated diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Sundance Biosciences Comparables

Compare Sundance Biosciences with similar companies based on industry and business-model similarity.

Sundance Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Myrobalan Therapeutics
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Sundance Biosciences Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Sundance Biosciences. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 6, 2026

    Grew 50% QoQ, from 8 to 12 employees.

  • May 6, 2026

    Grew 38% QoQ, from 8 to 11 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventOct 21, 2026

    Sundance attends the ACTRIMS-ECTRIMS Meeting and presents preclinical data on TYK2 inhibition in experimental autoimmune encephalomyelitis and cell culture experiments.

Book a demo to see all news

For institutional investors. Book with your work email.

Sundance Biosciences Filings

Explore SEC and related filing metadata, where available.

Sundance Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Sundance Biosciences's valuation, stock price, and market status.

Is Sundance Biosciences a public or private company?

Sundance Biosciences is a private company.

What is the current stock price of Sundance Biosciences?

Sundance Biosciences is a private company, so its shares have no public market price. Caplight tracks Sundance Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Sundance Biosciences worth (valuation)?

Valuation information for Sundance Biosciences is not publicly available.

Can I buy Sundance Biosciences stock?

Sundance Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Sundance Biosciences's last funding round?

Funding round information for Sundance Biosciences is not publicly available.

Who are the main investors in Sundance Biosciences?

Investor information for Sundance Biosciences is not publicly disclosed.

Will Sundance Biosciences IPO soon?

No public IPO plans have been announced for Sundance Biosciences.

How can I track Sundance Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in Sundance Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range12
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?